Adjunctive medical therapies for acute stroke thrombolysis: is there a CLEAR-ER choice?

Andrew D Barreto, Claudia Pedroza, James C Grotta, Andrew D Barreto, Claudia Pedroza, James C Grotta

No abstract available

Keywords: Bayes theorem; platelet glycoprotein GPIIb-IIIa complex; stroke; thrombolytic therapy.

Conflict of interest statement

Conflicts of Interest/Disclosures:

None

Figures

Figure 1

Prior and posterior probabilities of the log OR of combination therapy vs tPA alone. The prior probability assumes no difference between the two treatments with probability of OR>1 of 50%. The posterior probability is a combination of the prior and the data from the CLEAR-ER study. Area under the curve to the right of zero corresponds to the probability of combination therapy being better than tPA alone.